Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for CHURCH KEVIN
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-06-22
Sale
2022-06-24
7:25 pm
Athira Pharma Inc.ATHACHURCH KEVIN
Executive VP Research
2,614$2.69$7,03257,695
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-01-19
Option Award
2023-01-23
5:26 pm
N/A
2033-01-18
Athira Pharma Inc.ATHACHURCH KEVIN
Executive VP Research
150,000$0212,052
(Direct)
View
2023-01-19
Option Award
2023-01-23
5:26 pm
N/A
N/A
Athira Pharma Inc.ATHACHURCH KEVIN
Executive VP Research
657$2.74212,052
(Direct)
View
2022-10-28
Exercise
2022-10-31
8:17 pm
N/A
2028-12-17
Athira Pharma Inc.ATHACHURCH KEVIN
Executive VP Research
3,700$067,805
(Direct)
View
2022-10-28
Exercise
2022-10-31
8:17 pm
N/A
N/A
Athira Pharma Inc.ATHACHURCH KEVIN
Executive VP Research
3,700$1.3567,805
(Direct)
View
2022-06-22
Option Award
2022-06-24
7:25 pm
N/A
N/A
Athira Pharma Inc.ATHACHURCH KEVIN
Executive VP Research
10,000$057,695
(Direct)
View
2022-06-08
Exercise
2022-06-10
5:53 pm
N/A
2028-12-17
Athira Pharma Inc.ATHACHURCH KEVIN
Executive VP Research
2,500$060,419
(Direct)
View
2022-06-08
Option Award
2022-06-10
5:53 pm
N/A
N/A
Athira Pharma Inc.ATHACHURCH KEVIN
Executive VP Research
243$7.0660,419
(Direct)
View
2022-06-08
Exercise
2022-06-10
5:53 pm
N/A
N/A
Athira Pharma Inc.ATHACHURCH KEVIN
Executive VP Research
2,500$1.3560,419
(Direct)
View
2022-02-18
Exercise
2022-02-18
7:38 pm
N/A
N/A
Athira Pharma Inc.ATHACHURCH KEVIN
Executive VP Research
3,152$1.1947,566
(Direct)
View
2022-02-18
Exercise
2022-02-18
7:38 pm
N/A
2027-06-18
Athira Pharma Inc.ATHACHURCH KEVIN
Executive VP Research
3,152$047,566
(Direct)
View
2022-01-18
Option Award
2022-01-20
5:24 pm
N/A
2032-01-17
Athira Pharma Inc.ATHACHURCH KEVIN
Executive VP Research
100,000$0144,414
(Direct)
View
2022-01-18
Option Award
2022-01-20
5:24 pm
N/A
N/A
Athira Pharma Inc.ATHACHURCH KEVIN
Executive VP Research
96$12.51144,414
(Direct)
View
2021-05-18(A)
Option Award
2021-06-10
6:41 pm
N/A
N/A
Athira Pharma Inc.ATHACHURCH KEVIN
Vice President of Discovery
185$14.4544,318
(Direct)
View
2021-05-18(A)
Exercise
2021-06-10
6:41 pm
N/A
N/A
Athira Pharma Inc.ATHACHURCH KEVIN
Vice President of Discovery
3,152$1.0444,318
(Direct)
View
2021-05-18(A)
Exercise
2021-06-10
6:41 pm
N/A
2026-08-30
Athira Pharma Inc.ATHACHURCH KEVIN
Vice President of Discovery
3,152$044,318
(Direct)
View
2021-06-08
Exercise
2021-06-09
5:39 pm
N/A
N/A
Athira Pharma Inc.ATHACHURCH KEVIN
Vice President of Discovery
3,152$1.0444,133
(Direct)
View
2021-06-08
Exercise
2021-06-09
5:39 pm
N/A
2026-08-30
Athira Pharma Inc.ATHACHURCH KEVIN
Vice President of Discovery
3,152$044,133
(Direct)
View
2021-02-18
Option Award
2021-02-22
5:31 pm
N/A
2031-02-17
Athira Pharma Inc.ATHACHURCH KEVIN
Vice President of Discovery
20,000$020,000
(Direct)
View
2020-09-17
Ownership
2020-09-17
8:31 pm
N/A
N/A
Athira Pharma Inc.ATHACHURCH KEVIN
Vice President of Discovery
0$0129,880
(Direct)
View
(A) Indicate amendment filing.